Evidence Lacking On Proton Therapy For Non-Small-Cell Lung Cancer – BCBS
This article was originally published in The Gray Sheet
Executive Summary
Blue Cross Blue Shield’s Technology Evaluation Center found there is insufficient evidence that proton beam therapy improves health outcomes for patients with non-small-cell lung cancer.
You may also be interested in...
Data Lacking On Proton Therapy Vs. Traditional Radiation For Cancer - AHRQ
Particle beam radiation - also known as proton therapy - is a "promising" cancer treatment, but potential advantages over alternative radiation therapies remain unproven due to a lack of long-term comparative studies, according to a Sept. 14 Agency for Healthcare Research and Quality technical brief
Debate Stirs Over Medicare Coverage For Proton Therapy In Prostate Cancer
A private insurer is calling for CMS to issue a national non-coverage decision for proton therapy in treating prostate cancer, claiming Medicare payments will encourage rapid spread of the costly technology before there is enough clinical evidence to deem the treatment reasonable and necessary
Demand Grows For Proton Therapy Equipment Amid Calls For More Research
Burgeoning clinical adoption of resource-intensive proton radiation therapy for cancer creates unique challenges for payers, manufacturers, health care providers and patients, stakeholders say